Author

Kasper Bostlund Assersen

University of Southern DenmarkORCID 0000-0002-0889-3689Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Augusto PelusoiD· 1 shared André Felipe RodriguesiD· 1 shared Annette D. de KloetiD· 1 shared Antonina L. NazarovaiD· 1 shared Arkadiusz NawrockiiD· 1 shared Colin SumnersiD· 1 shared Eric G. KrauseiD· 1 shared Igor Maciel Souza SilvaiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Augusto PelusoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Angiotensin-(1-5) is a Potent Endogenous Angiotensin AT2-Receptor Agonist

Igor Maciel Souza Silva, A. Augusto Peluso, Khalid Elsaafien, Antonina L. Nazarova, Kasper Bostlund Assersen, Lucas Rodrigues‐Ribeiro, Mazher Mohammed, André Felipe Rodrigues, Arkadiusz Nawrocki, Lene Andrup Jakobsen, Pia Jensen, Annette D. de Kloet, Eric G. Krause, Mark P. Del Borgo, Ivan O. Maslov, , U. Muscha Steckelings

This study identifies angiotensin-(1-5) as a potent endogenous agonist of the AT2-receptor, showing its ability to increase nitric oxide release and lower blood pressure through AT2R-mediated mechanisms.

bioRxiv · Apr 5, 2024 · PreprintPharmacology & Toxicology